tiprankstipranks
ZyVersa Therapeutics’ Shareholder Approvals and Director Elections
PremiumCompany AnnouncementsZyVersa Therapeutics’ Shareholder Approvals and Director Elections
24d ago
ZyVersa highlights review article on inflammasome-induced inflammation
Premium
The Fly
ZyVersa highlights review article on inflammasome-induced inflammation
26d ago
ZyVersa Therapeutics announces publication of data on obesity, neuroinflammation
Premium
The Fly
ZyVersa Therapeutics announces publication of data on obesity, neuroinflammation
1M ago
ZyVersa Therapeutics announces publication of data on extracellular ASC
PremiumThe FlyZyVersa Therapeutics announces publication of data on extracellular ASC
4M ago
ZyVersa Therapeutics announces publication of data on inflammasome ASC
Premium
The Fly
ZyVersa Therapeutics announces publication of data on inflammasome ASC
4M ago
ZyVersa selects obesity, related metabolic implications at lead indication
Premium
The Fly
ZyVersa selects obesity, related metabolic implications at lead indication
4M ago
ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100
PremiumThe FlyZyVersa Therapeutics announces publication on ASC Inhibitor IC 100
7M ago
Zyversa Therapeutics Inc trading halted, news pending
Premium
The Fly
Zyversa Therapeutics Inc trading halted, news pending
7M ago
ZyVersa Therapeutics Approves Reverse Stock Split
Premium
Company Announcements
ZyVersa Therapeutics Approves Reverse Stock Split
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100